行情

OCX

OCX

ONCOCYTE
AMEX

实时行情|Nasdaq Last Sale

2.700
+0.080
+3.05%
交易中 14:01 02/20 EST
开盘
2.620
昨收
2.620
最高
2.700
最低
2.585
成交量
6.49万
成交额
--
52周最高
5.60
52周最低
1.500
市值
1.02亿
市盈率(TTM)
-6.7925
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OCX 新闻

  • 低利率的大背景下 市政债券或成“新贵”
  • 新浪财经-自媒体综合.2小时前
  • 巴以双方解除农产品贸易禁令
  • 新华网.3小时前
  • 联储二号人物给交易员"泼冷水" 这次市场共识又错了?
  • FX168.3小时前
  • 欧盟隐私机构警告谷歌收购Fitbit交易涉及隐私风险
  • 新浪美股.3小时前

更多

所属板块

生物技术和医学研究
-0.26%
制药与医学研究
-0.59%

热门股票

名称
价格
涨跌幅

OCX 简况

OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. It offers diagnostic tests for lung, breast and bladder cancer.
展开

Webull提供OncoCyte Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。